Abstract
To evaluate the use of HSV-based vectors for arthritis gene therapy we have constructed a first-generation, ICP4 deficient, replication defective herpes simplex virus (HSV) vector (S/0−) and a second-generation HSV vector derivative (T/0−) deficient for the immediate–early genes ICP4, 22 and 27, each carrying a soluble TNF receptor or IL-1 receptor antagonist transgene cassette. A rabbit synovial-fibroblast line in culture, infected by either vector enabled high-level expression of the transgene product. However, following a single intra-articular injection of the vectors into rabbit knee joints, only the second-generation, HSV T/0− vector expressed detectable levels of soluble TNFR in synovial fluid. Synovial lavage fluid from inoculated joints con- tained up to 12 ng/ml of soluble receptor that persisted at detectable, but reduced levels for at least 7 days. When tested in an experimental model of arthritis generated by intra-articular overexpression of interleukin-1β using retrovirus transduced synovial cells, the HSV T/0− vector expressing the interleukin-1 receptor antagonist was found to inhibit leukocytosis and synovitis significantly. The improved levels and duration of intra-articular transgene expression achieved via HSV-mediated gene delivery suggest that an HSV vector system could be used for therapeutic applications in patients with rheumatoid arthritis (RA) and other joint-related inflammatory diseases.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Evans CH et al. Gene therapy in autoimmune diseases Ann Rheum Dis 1998 57: 125–127
Evans CH et al. Gene therapy for rheumatic diseases Arthritis Rheum 1999 42: 1–16
Bandara G et al. Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer Proc Natl Acad Sci USA 1993 90: 10764–10768
Hung G et al. Suppression of intra-articular responses to interleukin-1 by transfer of the interleukin-1 receptor antagonist gene to synovium Gene Therapy 1994 1: 64–69
Otani K et al. Suppression of antigen-induced arthritis in rabbits by ex vivo gene therapy J Immunol 1996 156: 3558–3562
Evans CH et al. Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis Hum Gene Ther 1996 7: 1261–1280
Ghivizzani SC et al. Direct retrovirus-mediated gene transfer to the synovium of the rabbit knee: implications for arthritis gene therapy Gene Therapy 1997 4: 977–982
Nita I et al. Direct gene delivery to synovium. An evaluation of potential vectors in vitro and in vivo Arthritis Rheum 1996 39: 820–828
Roessler BJ et al. Adenoviral-mediated gene transfer to rabbit synovium in vivo J Clin Invest 1993 92: 1085–1092
Yovandich J et al. Gene transfer to synovial cells by intra-articular administration of plasmid DNA Hum Gene Ther 1995 6: 603–610
Tomita T et al. In vivo direct gene transfer into articular cartilage by intraarticular injection mediated by HVJ (Sendai virus) and liposomes Arthritis Rheum 1997 40: 901–906
Ghivizzani SC et al. Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects Proc Natl Acad Sci USA 1998 95: 4613–4618
Evans CH, Ghivizzani SC, Robbins PD . Blocking cytokines with genes J Leukocyte Biol 1998 64: 55–61
Glorioso JC et al. Progress in the development of herpes simplex virus gene vectors for treatment of rheumatoid arthritis Adv Drug Del Rev 1997 27: 41–57
Campbell MEM, Palfeyman JW, Preston CM . Identification of herpes simplex virus DNA sequences which encode a trans-acting polypeptide responsible for stimulation of immediate early transcription J Mol Biol 1984 180: 1–19
Mackem S, Roizman B . Differentiation between alpha promoter and regulatory regions of herpes simplex virus type 1: the functional domains and sequence of a movable alpha regulator Proc Natl Acad Sci USA 1982 79: 4917–4921
DeLuca NA, McCarthy AM, Schaffer PA . Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate–early regulatory protein ICP4 J Virol 1985 56: 558–570
DeLuca NA, Schaffer PA . Activation of immediate–early, early, and late promoters by temperature-sensitive and wild-type forms of herpes simplex virus type 1 protein ICP4 Mol Cell Biol 1985 5: 1997–2008
Krisky DM et al. Deletion of multiple immediate–early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons Gene Therapy 1998 5: 1593–1603
Georgescu HI, Mendelow D, Evans CH . An established cell line from rabbit periarticular soft tissue which retains the ‘activatable’ phenotype In Vitro 1988 24: 1015–1022
Ghivizzani SC et al. Constitutive intra-articular expression of human IL-1 beta following gene transfer to rabbit synovium produces all major pathologies of human rheumatoid arthritis J Immunol 1997 159: 3604–3612
Roessler B et al. Inhibition of interleukin-1 induced effects in synoviocytes transduced with human IL-1 receptor antagonist cDNA using an adenviral vector Hum Gene Ther 1995 6: 307–316
Samaniego LA, Neiderhiser L, DeLuca NA . Persistence and expression of the herpes simplex virus genome in the absence of immediate–early proteins J Virol 1998 72: 3307–3320
Fisher KJ et al. Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis Virology 1996 217: 11–22
Kochanek S et al. A new adenoviral vector: replacement of all viral coding sequences with 28kb of DNA independently expressing both full-length Dystrophin and β-galactosidase Proc Natl Acad Sci USA 1996 93: 5731–5736
Krisky DM et al. Rapid method for construction of recombinant HSV gene transfer vectors Gene Therapy 1997 4: 1120–1125
Peppel K, Crawford D, Beutler B . A tumor necrosis factor (TNF) receptor-Ig heavy chain chimeric protein as a bivalent antagonist of TNF activity J Exp Med 1991 174: 1483–1489
McGeoch DJ et al. The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1 J Gen Virol 1988 69: 1531–1574
Acknowledgements
This work was supported by National Institute of Health grants NIH-NIAMS-96–1 (PDR) and 5R01 AR44526–02 (JCG).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Oligino, T., Ghivizzani, S., Wolfe, D. et al. Intra-articular delivery of a herpes simplex virus IL-1Ra gene vector reduces inflammation in a rabbit model of arthritis. Gene Ther 6, 1713–1720 (1999). https://doi.org/10.1038/sj.gt.3301014
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3301014
Keywords
This article is cited by
-
Adeno-Associated Viral Vectors Show Serotype Specific Transduction of Equine Joint Tissue Explants and Cultured Monolayers
Scientific Reports (2014)
-
scAAV-mediated gene transfer of interleukin-1-receptor antagonist to synovium and articular cartilage in large mammalian joints
Gene Therapy (2013)
-
La terapia genica nella riparazione cartilaginea
Archivio di Ortopedia e Reumatologia (2009)
-
Gene transfer to interfere with TNFα signaling in neuropathic pain
Gene Therapy (2007)